S Hoffe1, J M Frakes1, T A Aguilera2, B Czito3, M Palta4, M Brookes5, C Schweizer6, L Colbert7, S Moningi8, M S Bhutani9, S Pant10, C W Tzeng11, R S Tidwell12, P Thall13, Y Yuan9, E C Moser5, J Holmlund14, J Herman15, C M Taniguchi16. 1. H. Lee Moffitt Cancer Center and Research Institute, Department of Radiation Oncology, Tampa, FL. 2. Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX. 3. Duke University Medical Center, Durham, NC. 4. Duke University Medical Center, Department of Radiation Oncology, Durham, NC. 5. Galera, Malvern, PA. 6. Galera Therapeutics, Malvern, PA. 7. The University of Texas MD Anderson Cancer Center, Houston, TX. 8. Johns Hopkins University School of Medicine, Baltimore, MD. 9. MD Anderson Cancer Center, Houston, TX. 10. (10)University of Oklahoma Health Science Center, Stephenson Cancer Center, Department of Hematology & Oncology, Oklahoma City, OK. 11. (11)The Univ of Texas MD Anderson Cancer Center, Houston, TX. 12. (12)MD Anderson Cancer Center, Department of Biostatistics, Houston, TX. 13. (13)Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. 14. (14)Galera Therapeutics Inc., Malvern, PA. 15. (15)Northwell Health Cancer Institute, Lake Success, NY. 16. (16)UT MD Anderson Cancer Center, Houston, TX; (17)Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Authors: Carolina J García García; Ariana C Acevedo Diaz; Neeraj Kumari; Suman Govindaraju; Marimar de la Cruz Bonilla; F Anthony San Lucas; Nicholas D Nguyen; Iancarlos Jiménez Sacarello; Helen Piwnica-Worms; Anirban Maitra; Cullen M Taniguchi Journal: Front Oncol Date: 2021-11-25 Impact factor: 6.244
Authors: Shalini Moningi; Xiudong Lei; Penny Fang; Cullen M Taniguchi; Emma B Holliday; Eugene J Koay; Albert C Koong; Ethan B Ludmir; Bruce D Minsky; Prajnan Das; Sharon H Giordano; Grace L Smith Journal: Clin Transl Radiat Oncol Date: 2022-04-19